anonymous
Guest
anonymous
Guest
All of this is SO TRUE. Busy work, too many district CC, expense report ladies who sit around reviewing reports , looking for reasons
to not approve something!
to not approve something!
So happy to be out of that shit hole. Manager was a micro manager who asked for constant busy work, 10+ Action item emails/day, multiple conf calls/week etc. May have been a good rep but definitely not a good manager. His new district will bail soon. Bet on it.
Good question. Why is Zipsor expected to simply maintain share, is only 10% of bonus, and Zipsor has multiple reps promoting it, VERSUS Cambia, is in growth mode, CNS 30% of bonus, and very few reps promoting it. 25% share of voice vs. pre - expansion. Why are a decent percentage of prescriptions for Nucynta being written by non-targets that are not even on anyone's radar? Go to your weeklies and filter through to false targets, and you'll be shocked at what is being written by providers that are not even in your data base. Many WHYs. Shame on Depomed.Why is Nucynta ER weighted so heavily for CNS team? Neuros don't use LAOs...
So happy to be out of that shit hole. Manager was a micro manager who asked for constant busy work, 10+ Action item emails/day, multiple conf calls/week etc. May have been a good rep but definitely not a good manager. His new district will bail soon. Bet on it.
So happy to be out of that shit hole. Manager was a micro manager who asked for constant busy work, 10+ Action item emails/day, multiple conf calls/week etc. May have been a good rep but definitely not a good manager. His new district will bail soon. Bet on it.